MEDAG and breast cancer: Li et al., recently showed MEDA-4 expression negatively correlated with breast cancer patient survival and confirmed the role of MEDA-4 in promoting epithelial-to-mesenchymal transition (EMT), in an AKT-dependent manner, using breast cancer cell lines [137], showing the importance of MEDA-4 in breast cancer pathogenesis.